AAAAAA

   
Results: 1-21 |
Results: 21
SUBCUTANEOUS INTERLEUKIN-2 AND INTERFERON-ALPHA THERAPY ASSOCIATED WITH CISPLATIN MONOCHEMOTHERAPY IN THE TREATMENT OF METASTATIC MELANOMA
Authors: ANDRES P CUPISSOL D GUILLOT B AVRIL MF DRENO B
Citation: P. Andres et al., SUBCUTANEOUS INTERLEUKIN-2 AND INTERFERON-ALPHA THERAPY ASSOCIATED WITH CISPLATIN MONOCHEMOTHERAPY IN THE TREATMENT OF METASTATIC MELANOMA, EJD. European journal of dermatology, 8(4), 1998, pp. 235-239
USE OF GRANISETRON IN PATIENTS REFRACTORY TO PREVIOUS TREATMENT WITH ANTIEMETICS
Authors: CARMICHAEL J KEIZER HJ CUPISSOL D MILLIEZ J SCHEIDEL P SCHINDLER AE
Citation: J. Carmichael et al., USE OF GRANISETRON IN PATIENTS REFRACTORY TO PREVIOUS TREATMENT WITH ANTIEMETICS, Anti-cancer drugs, 9(5), 1998, pp. 381-385
CONTROL OF DELAYED NAUSEA AND VOMITING WITH GRANISETRON PLUS DEXAMETHASONE OR DEXAMETHASONE ALONE IN PATIENTS RECEIVING HIGHLY EMETOGENIC CHEMOTHERAPY - A DOUBLE-BLIND, PLACEBO-CONTROLLED, COMPARATIVE-STUDY
Authors: GOEDHALS L HERON JF KLEISBAUER JP PAGANI O SESSA C GIGER K CAVALLI F LUDWIG C AAPRO M BLEIBERG H DEWASH G DICATO M TAGNON A VANSTRAELEN D VINDEVOGHEL A ABRATT R FALKSON G BARLEY V CARMICHAEL J COLEMAN R DAVIDSON N GRIEVE R HARPER P ROBERTS J RUSTIN G NAMAN H SCHNEIDER M NOBLE A NETTER P CUPISSOL D BALMES P CALS L KHAYAT D CATIMEL G DUTIN JP BOUFETTE P ADENIS L MISSET J COLLERY P NOUVET G CHAVAILLON JM BLANCHON F POIRIER R ARNAUD A LECAER H CARLES P MUIR J BONNAUD F MARQUESTE L CLAVIER J GUERIN J TAYTARD A KEIZER H NORTIER J SLEE P WILS J RODENBURG C BURGHOUTS J DEWIT R GARCIAGIRON C JIMENEZLACAVE A CRUZHERNANDEZ J MASSUTISUREDA B HANS K FUCHS R KRIEGMAIR M SCHULLER J LAHOUSEN M PANNUTI F MONFARDINI S NILSSON S
Citation: L. Goedhals et al., CONTROL OF DELAYED NAUSEA AND VOMITING WITH GRANISETRON PLUS DEXAMETHASONE OR DEXAMETHASONE ALONE IN PATIENTS RECEIVING HIGHLY EMETOGENIC CHEMOTHERAPY - A DOUBLE-BLIND, PLACEBO-CONTROLLED, COMPARATIVE-STUDY, Annals of oncology, 9(6), 1998, pp. 661-666
CHEMOTHERAPY IN CARCINOMAS OF UNKNOWN PRIMARY SITE (CUP) - A HIGH-DOSE INTENSITY POLICY
Authors: CULINE S FABBRO M YCHOU M ROMIEU G CUPISSOL D PUJOL H
Citation: S. Culine et al., CHEMOTHERAPY IN CARCINOMAS OF UNKNOWN PRIMARY SITE (CUP) - A HIGH-DOSE INTENSITY POLICY, Annals of oncology, 9, 1998, pp. 231-231
CARCINOMAS OF UNKNOWN PRIMARY SITE - A STUDY BASED ON 100 PATIENTS TREATED AT THE MONTPELLIER-CANCER-CENTER
Authors: CULINE S GAZAGNE L YCHOU M ROMIEU G FABBRO M CUPISSOL D DUBOIS JB
Citation: S. Culine et al., CARCINOMAS OF UNKNOWN PRIMARY SITE - A STUDY BASED ON 100 PATIENTS TREATED AT THE MONTPELLIER-CANCER-CENTER, La Revue de medecine interne (Paris), 19(10), 1998, pp. 713-719
RANDOMIZED TRIAL OF INTERFERON ALPHA-2A AS ADJUVANT THERAPY IN RESECTED PRIMARY MELANOMA THICKER THAN 1-CENTER-DOT-5 MM WITHOUT CLINICALLY DETECTABLE NODE METASTASES
Authors: GROB JJ DRENO B DELASALMONIERE P DELAUNAY M CUPISSOL D GUILLOT B SOUTEYRAND P SASSOLAS B CESARINI JP LIONNET S LOK C CHASTANG C BONERANDI JJ
Citation: Jj. Grob et al., RANDOMIZED TRIAL OF INTERFERON ALPHA-2A AS ADJUVANT THERAPY IN RESECTED PRIMARY MELANOMA THICKER THAN 1-CENTER-DOT-5 MM WITHOUT CLINICALLY DETECTABLE NODE METASTASES, Lancet, 351(9120), 1998, pp. 1905-1910
THE EFFICACY OF A COMBINATION OF ONDANSETRON, METHYLPREDNISOLONE AND METOPIMAZINE IN PATIENTS PREVIOUSLY UNCONTROLLED WITH A DUAL ANTIEMETIC TREATMENT IN CISPLATIN-BASED CHEMOTHERAPY
Authors: LEBEAU B DEPIERRE A GIOVANNINI M RIVIERE A KALUZINSKI L VOTAN B HEDOUIN M DALLENS H AUBIER M BACHAUD JM BALMES P BERNARD JP BIRON E BONNAUD F BONSROSSET F BOUFFETTE P BOYER J BRUNET R CAILLAUD D CALAIS G CAPDEVILLE J CATRYTHOMAS I CHAUMIER P CHAVAILLON JM CHEVALLIER B CLAVIER J CONSTANS P CUPISSOL D DAVID P DELZENNE A DERENNE JP ESCAMILLA R EYMARD JC FABBRO M FABRE V FAYOLLE V FOURNEL P FRANCHI C FRUGE I GUERIN JC GOUEROU H HADJADJ D KELKEL E LACROIX H LEBOURGEOIS JP LEBRUN D LUCAS P MARTIN M MARTY M MATHIEU JP MEURISSE MP MITAL P MORO D MUIR JF ORFEUVRE H PERPOINT B QUOIX E REBISCHUNG JL REBOULET V RIOU R SALTIEL JC SLAWINSKI JC SEVIN D TAULELLE M TUBIANA N VOLOCH A WEITZENBLUM E ZYLBERBERG R
Citation: B. Lebeau et al., THE EFFICACY OF A COMBINATION OF ONDANSETRON, METHYLPREDNISOLONE AND METOPIMAZINE IN PATIENTS PREVIOUSLY UNCONTROLLED WITH A DUAL ANTIEMETIC TREATMENT IN CISPLATIN-BASED CHEMOTHERAPY, Annals of oncology, 8(9), 1997, pp. 887-892
4-STEP HIGH-DOSE SEQUENTIAL CHEMOTHERAPY WITH HEMATOPOIETIC PROGENITOR-CELL SUPPORT AS INDUCTION TREATMENT FOR PATIENTS WITH SOLID TUMORS
Authors: CULINE S FABBRO M ASSENS C YCHOU M ROMIEU G KRAMAR A CUPISSOL D PINGUET F PUJOL H
Citation: S. Culine et al., 4-STEP HIGH-DOSE SEQUENTIAL CHEMOTHERAPY WITH HEMATOPOIETIC PROGENITOR-CELL SUPPORT AS INDUCTION TREATMENT FOR PATIENTS WITH SOLID TUMORS, Annals of oncology, 8(10), 1997, pp. 951-956
PHASE-II TRIAL OF OXALIPLATIN (L-OHP) IN ADVANCED, RECURRENT AND OR METASTATIC SQUAMOUS-CELL CARCINOMA OF THE HEAD AND NECK/
Authors: DEGARDIN M CAPPELAERE P KRAKOWSKI I FARGEOT P CUPISSOL D BRIENZA S
Citation: M. Degardin et al., PHASE-II TRIAL OF OXALIPLATIN (L-OHP) IN ADVANCED, RECURRENT AND OR METASTATIC SQUAMOUS-CELL CARCINOMA OF THE HEAD AND NECK/, European journal of cancer. Part B, Oral oncology, 32B(4), 1996, pp. 278-279
A DOUBLE-BLIND, RANDOMIZED, PARALLEL STUDY OF IV DOLASETRON MESILATE VERSUS IV METOCLOPRAMIDE IN PATIENTS RECEIVING MODERATELY EMETOGENIC CHEMOTHERAPY
Authors: FAUSER AA BLEIBERG H CHEVALLIER B FAVRE R FABBRO M NOBLE A CUPISSOL D DEGARDIN M CAPPELAERE P SPAETH D CLAVERIE N
Citation: Aa. Fauser et al., A DOUBLE-BLIND, RANDOMIZED, PARALLEL STUDY OF IV DOLASETRON MESILATE VERSUS IV METOCLOPRAMIDE IN PATIENTS RECEIVING MODERATELY EMETOGENIC CHEMOTHERAPY, The Cancer journal, 9(4), 1996, pp. 196-202
FOLLOW-UP OF 153 MELANOMA EVALUABLE PATIENTS TREATED BY FOTEMUSTINE -PROGNOSIS FACTORS FOR RESPONSE AND SURVIVAL
Authors: KHAYAT D BANZET P WEIL M FUMOLEAU P AVRIL MF NAMER M BONNETERRE J KERBRAT P BONERANDI JJ BUGAT R MONTCUQUET P CUPISSOL D LAUVIN R VILMER C BOAZIZ C COUR V BIZZARI JP
Citation: D. Khayat et al., FOLLOW-UP OF 153 MELANOMA EVALUABLE PATIENTS TREATED BY FOTEMUSTINE -PROGNOSIS FACTORS FOR RESPONSE AND SURVIVAL, Medicamentos de actualidad, 32, 1996, pp. 35-41
ARE MORE ANTIEMETIC TRIALS WITH A PLACEBO NECESSARY - REPORT OF PATIENT DATA FROM RANDOMIZED TRIALS OF PLACEBO ANTIEMETICS WITH CISPLATIN
Authors: KRIS MG CUBEDDU LX GRALLA RJ CUPISSOL D TYSON LB VENKATRAMAN E HOMESLEY HD
Citation: Mg. Kris et al., ARE MORE ANTIEMETIC TRIALS WITH A PLACEBO NECESSARY - REPORT OF PATIENT DATA FROM RANDOMIZED TRIALS OF PLACEBO ANTIEMETICS WITH CISPLATIN, Cancer, 78(10), 1996, pp. 2193-2198
VALIDATION OF A NEW INTERACTIVE SOFTWARE MONITORING A CONTROLLED-FLOWINFUSION-PUMP FOR CISPLATIN DOSAGE REGIMEN ADJUSTMENT
Authors: CUPISSOL D BRES J GESTINBOYER C NOUGUIERSOULE J VIAN L TEP A NOUGUIER J
Citation: D. Cupissol et al., VALIDATION OF A NEW INTERACTIVE SOFTWARE MONITORING A CONTROLLED-FLOWINFUSION-PUMP FOR CISPLATIN DOSAGE REGIMEN ADJUSTMENT, Bulletin du cancer, 83(8), 1996, pp. 664-676
IS NAVOBAN(R) (TROPISETRON) AS EFFECTIVE AS ZOFRAN(R) (ONDANSETRON) IN CISPLATIN-INDUCED EMESIS
Authors: MARTY M KLEISBAUER JP FOURNEL P VERGNENEGRE A CARLES P LORIAKANZA Y SIMONETTA C DEBRUIJN KM LAURAINE P DIDIER A CUPISSOL D BERGERAT JP PUJAZON MC HERON JF DRENO B TAYTARD A GUERIN JC CLAVIER J ROBINET G BLANCHON F BALMES P MUIR JF PAILLOTIN D POIRIER R BONNETERRE J MELLONI B ROCHE H DEPIERRE A PLAGNE R SOUQUET PJ ARMAND JP DEFORNI M
Citation: M. Marty et al., IS NAVOBAN(R) (TROPISETRON) AS EFFECTIVE AS ZOFRAN(R) (ONDANSETRON) IN CISPLATIN-INDUCED EMESIS, Anti-cancer drugs, 6, 1995, pp. 15-21
EFFICACY OF LENOGRASTIM ON HEMATOLOGIC TOLERANCE TO MAID CHEMOTHERAPYIN PATIENTS WITH ADVANCED SOFT-TISSUE SARCOMA AND CONSEQUENCES ON TREATMENT DOSE-INTENSITY
Authors: BUI BN CHEVALLIER B CHEVREAU C KRAKOWSKI I PENY AM THYSS A MAUGARDLOUBOUTIN C CUPISSOL D FARGEOT P BONICHON F COINDRE JM GIL B COURCHABERNAUD V
Citation: Bn. Bui et al., EFFICACY OF LENOGRASTIM ON HEMATOLOGIC TOLERANCE TO MAID CHEMOTHERAPYIN PATIENTS WITH ADVANCED SOFT-TISSUE SARCOMA AND CONSEQUENCES ON TREATMENT DOSE-INTENSITY, Journal of clinical oncology, 13(10), 1995, pp. 2629-2636
STANDARDS, OPTIONS AND GUIDELINES FOR THE USE OF ANTIEMETICS IN ONCOLOGY
Authors: RIVIERE A BECKENDORF V BONNETERRE J BUI NB CATIMEL G CUPISSOL D FARGEOT P HECQUET B KRAKOWSKI I MADELAINECHAMBRIN I MIHURA J ROCHE H RUFFIE P SCHNEIDER M PHILIP T
Citation: A. Riviere et al., STANDARDS, OPTIONS AND GUIDELINES FOR THE USE OF ANTIEMETICS IN ONCOLOGY, Bulletin du cancer, 82, 1995, pp. 453-485
A DOUBLE-BLIND, RANDOMIZED, CROSSOVER COMPARISON OF GRANISETRON AND ONDANSETRON IN 5-DAY FRACTIONATED CHEMOTHERAPY - ASSESSMENT OF EFFICACY, SAFETY AND PATIENT PREFERENCE
Authors: NOBLE A BREMER K GOEDHALS L CUPISSOL D DILLY SG
Citation: A. Noble et al., A DOUBLE-BLIND, RANDOMIZED, CROSSOVER COMPARISON OF GRANISETRON AND ONDANSETRON IN 5-DAY FRACTIONATED CHEMOTHERAPY - ASSESSMENT OF EFFICACY, SAFETY AND PATIENT PREFERENCE, European journal of cancer, 30A(8), 1994, pp. 1083-1088
A DOSE-FINDING STUDY OF GRANISETRON, A NOVEL ANTIEMETIC, IN PATIENTS RECEIVING HIGH-DOSE CISPLATIN
Authors: GOEDHALS L JORDAAN JP KAYE SB ARMAND JP VEENHOF CHN FALKSON G SOUKOP M SCHNEIDER M OBERLING F BUI BN ROCHE H ADENIS L CATY A BLIJHAM GH DEWEWEIRE A COIFFIER B SOTTO JJ VANHEUKELOM LS TAGNON A SLEE PHTJ KROEKS MVAM RAVEZ P CUPISSOL D KEIZER HJ BRUNNER K CALVERT AH YERNAULT JC LIBERT P BROHEE D
Citation: L. Goedhals et al., A DOSE-FINDING STUDY OF GRANISETRON, A NOVEL ANTIEMETIC, IN PATIENTS RECEIVING HIGH-DOSE CISPLATIN, Supportive care in cancer, 2(3), 1994, pp. 177-183
INHIBITION OF DIHYDROPYRIMIDINE DEHYDROGENASE BY ALPHA-INTERFERON - EXPERIMENTAL-DATA ON HUMAN TUMOR-CELL LINES
Authors: MILANO G FISCHEL JL ETIENNE MC RENEE N FORMENTO P THYSS A GASPARD MH THILL L CUPISSOL D
Citation: G. Milano et al., INHIBITION OF DIHYDROPYRIMIDINE DEHYDROGENASE BY ALPHA-INTERFERON - EXPERIMENTAL-DATA ON HUMAN TUMOR-CELL LINES, Cancer chemotherapy and pharmacology, 34(2), 1994, pp. 147-152
ULTRADIAN VARIATIONS OF IL-1-BETA, IFN-GA MMA AND RIL-2 CONCENTRATIONS IN HEALTHY-VOLUNTEERS
Authors: BOUAYADAMINE D CUPISSOL D NOUGIERSOULE J BRES J GESTINBOYER C RENE C ASSENS C SERROU B
Citation: D. Bouayadamine et al., ULTRADIAN VARIATIONS OF IL-1-BETA, IFN-GA MMA AND RIL-2 CONCENTRATIONS IN HEALTHY-VOLUNTEERS, Comptes rendus des seances de la Societe de biologie et de ses filiales, 187(4), 1993, pp. 542-553
EVALUATION OF THE BIOEQUIVALENCE OF TABLET AND CAPSULE FORMULATIONS OF GRANISETRON IN PATIENTS UNDERGOING CYTOTOXIC CHEMOTHERAPY FOR MALIGNANT DISEASE
Authors: CUPISSOL D BRESSOLLE F ADENIS L CARMICHAEL J BESSELL E ALLEN A WARGENAU M ROMAIN D
Citation: D. Cupissol et al., EVALUATION OF THE BIOEQUIVALENCE OF TABLET AND CAPSULE FORMULATIONS OF GRANISETRON IN PATIENTS UNDERGOING CYTOTOXIC CHEMOTHERAPY FOR MALIGNANT DISEASE, Journal of pharmaceutical sciences, 82(12), 1993, pp. 1281-1284
Risultati: 1-21 |